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Background: Although migraine is one of the most common primary headaches, its therapy is still limited in many
cases. The use of animal models is crucial in the development of novel therapeutic strategies, but unfortunately,
none of them show all aspects of the disease, therefore, there is a constant need for further improvement in this
field. The application of inflammatory agents on the dura mater is a widely accepted method to mimic neurogenic
inflammation in rodents, which plays a key role in the pathomechanism of migraine. Complete Freund’s Adjuvant
(CFA), and a mixture of inflammatory mediators, called inflammatory soup (IS) are often used for this purpose.
Methods: To examine the activation pattern that is caused by chemical stimulation of dura mater, we applied CFA
or IS over the right parietal lobe. After 2 h and 4 h (CFA groups), or 2.5 h and 4 h (IS groups), animals were perfused,
and c-Fos immunoreactive cells were counted in the caudal trigeminal nucleus. To explore every pitfall, we
examined whether our surgical procedure (anesthetic drug, stereotaxic apparatus, local lidocaine) can alter the
results under the same experimental settings. c-Fos labeled cells were counted in the second-order neuron area
based on the somatotopic organization of the trigeminal nerve branches.
Results: We could not find any difference between the CFA and physiological saline group neither 2 h, nor 4 h after
dural stimulation. IS caused significant difference after both time points between IS treated and control group, and
between treated (right) and control (left) side. Stereotaxic frame usage had a substantial effect on the obtained results.
Conclusions: Counting c-Fos immunoreactive cells based on somatotopic organization of the trigeminal nerve helped to
examine the effect of chemical stimulation of dura in a more specific way. As a result, the use of IS over the parietal lobe
caused activation in the area of the ophthalmic nerve. To see this effect, the use of lidocaine anesthesia is indispensable.
In conclusion, application of IS on the dura mater induces short-term, more robust c-Fos activation than CFA, therefore it
might offer a better approach to model acute migraine headache in rodents.
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According to the Global Burden of Disease Study [1],
migraine is the third highest cause of disability world-
wide in both men and women. Although many specific
drugs are available, the treatment of migraine is limited
in many cases [2]. Its exact pathophysiology is still un-
known, which makes drug development even more chal-
lenging. It is known that during the migraine attack the
trigeminal system becomes sensitized and remains over-
active, but there are several hypotheses about the initial
cause without a clear answer [3]. Finding a reliable ani-
mal model would be crucial, though a model which
shows all the aspects of the disease is still not available.
Use of Complete Freund’s Adjuvant (CFA) or inflamma-
tory soup (IS) on the dural surface is a proven useful
method to cause trigeminal activation and sensitization
in rats and these agents can stimulate neurogenic in-
flammation [4]. In this model, the activation and
sensitization of the second-order sensory neurons occur
between 2 and 4 h after application of IS similar to the
cutaneous allodynia in migraine patients [5, 6].
The three sensory branches of trigeminal nerve supply
the innervation of the dura mater [7, 8] and their soma-
totopic representation in the brainstem is already well
described [9, 10]. However, the effect of chemical stimu-
lation of the dura has never been studied before in re-
gard to the representation of the nerve branches.
Expression of Fos protein is a well-known marker of
activation in the trigeminovascular system [11]. In the
chemical activation model, c-Fos expression might be in-
duced by many stimuli (anesthetic drug, skin incision,
ear bars of the stereotaxic apparatus, meningeal irrita-
tion, etc.) [12]. Knowing these effects would be essential
for the proper analysis of the specific stimulus, to avoid
pitfalls of the model. Thus, the aim of our study is to
characterize the neuronal activation using two different
inflammatory agents on the dura of rats and to deter-
mine the effects of surgery, and other altering factors on
the expression of the Fos protein.
Methods
Animals
Forty-eight adult male Sprague-Dawley rats (weight
240–430 g) were used. The animals were raised and
housed under standard laboratory conditions, light-dark
cycle 12–12 h, regular rat chow and water ad libitum.
The procedures used in our study were approved by the
Committee of the Animal Research of University of Sze-
ged (I-74-49/2017) and the Scientific Ethics Committee
for Animal Research of the Protection of Animals Advis-
ory Board (XI./1098/2018), and followed the guidelines
the Use of Animals in Research of the International As-
sociation for the Study of Pain and the directive of the
European Parliament (2010/63/EU).Inflammatory substances, drugs
We used two different inflammatory agents on the dura
mater: CFA contained dried, inactivated Mycobacterium
tuberculosis in mineral oil (Sigma-Aldrich, St. Louis,
MO, USA) and IS contained 1mM bradykinin, 100 μM
prostaglandin, 1 mM serotonin, 1 mM histamine, (pH
5.0) in 10mM HEPES buffer. Control groups received
0.9% physiological saline or synthetic interstitial fluid
(SIF) (135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 5 mM
CaCl2, 10 mM glucose, in 10 mM HEPES buffer, pH 7.3).
Lidocaine (20 mg/mL; Egis, Budapest, Hungary) was di-
luted with physiological saline to have a final concentra-
tion of 10 mg/ml (1%).
Experimental groups
Unstimulated animals
Two groups of animals with no surgery/surgical
intervention.
NAT group
Animals were anesthetized and fixed in a stereotaxic ap-
paratus for the same time period as the animals in
2CFA/2PHYS group (n = 3).
FRE group
Animals were anesthetized and placed on a heating pad
as long as the procedure of the 2CFA or 2PHYS animals
was held (n = 3).
2PHYS/2CFA; 4PHYS/4CFA groups
Animals underwent surgery, on the dural surface physio-
logical saline (PHYS groups) or CFA (CFA groups) was
applied. The survival time was 2 (2PHYS/2CFA) or 4 h
(4PHYS/4CFA) after the CFA/saline treatment (n = 4,
n = 4; n = 3; n = 3).
LCFA/LPHYS groups
Rats in these groups underwent the same procedure as
2CFA and 2PHYS groups, but lidocaine was used to
anesthetize the scalp before the incision was made on
the head (n = 2, n = 2).
2SIF/2IS; 4SIF/4IS groups
2.5- or 4-h survival time was chosen to make sure we
avoid activation due to the surgery. Animals in these
groups had the same surgical procedure as rats in
LCFA/LPHYS group, received dural SIF/IS treatment
and were perfused after 2.5 h (2SIF/2IS) or 4 h (4IS/
4SIF) (n = 6/group) (Fig. 1a).
Procedures
The animals were deeply anesthetized using 4% chloral
hydrate (400 mg/kg; intraperitoneal (i.p.)) and placed in
a stereotaxic apparatus. The scalp was anesthetized by
Fig. 1 a: Schematic timeline of the experimental design. The CFA/saline/IS/SIF treatment was considered as “0” timepoint. LCFA, LPHYS, 2IS, 2SIF,
4IS, 4SIF groups received lidocaine before the skin incision. 20 min after dural treatment, the surface of the dura was rinsed off with either saline
or SIF. Animals in NAT and FRE groups were only anesthetized and placed in a stereotaxic frame (NAT) or left on a heating pad (FRE) as long as
animals in other groups. b: Schematic figure of trigeminal pain pathway. Dermatome distribution of the trigeminal nerve divisions of the face.
Trigeminal ganglion contains the first-order neurons, second-order neurons are found in the spinal cord and medulla. Schematic figure of the
dorsal horn shows the somatotopic representation of the three branches of the trigeminal nerve. The ventral (darkest), intermediate and dorsal
part of the dorsal horn considered to be equivalent to the area of the ophthalmic (V/1), maxillary (V/2), and mandibular (V/3) branch. Figure of
the coronal brain section represents the third-order neurons in the thalamus (Th) and neurons in the primary somatosensory cortex (S1)
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LCFA, LPHYS, 2SIF, 2IS, 4SIF, 4IS groups. A 2mm×2mm
hole (5mm posterior from the bregma and 3mm lateral of
the midline, above the right hemisphere) was carefully drilled
with slow speed, using saline for cooling, avoiding any injury
of the dura mater. On the dural surface 10 μL CFA (in
groups 2CFA, 4CFA, LCFA) or IS (2IS, 4IS) was applied.
Control groups received physiological saline (2PHYS,
4PHYS, LPHYS groups) or SIF (in groups 2SIF, 4SIF). To
prevent the local spreading of the chemicals, we adjusted
the position of the head in the stereotaxic frame, so the
dorsal surface of the skull was horizontal. After 20min the
area was washed with either physiological saline or SIF.
To prevent drying out of the dura saline or SIF soakedcotton ball was placed carefully on top. After the surgery
animals were kept under anesthesia and placed on a heat-
ing pad. The rats were transcardially perfused 2 h (2PHYS,
2CFA, LPHYS, LCFA, NAT, FRE), 2.5 h (2IS, 2SIF) or 4 h
(4PHYS, 4CFA, 4IS, 4SIF) after the application of the in-
flammatory mediators. For the perfusion 50mL of 0.1M
phosphate-buffered saline (PBS) and 200mL of 4%
phosphate-buffered paraformaldehyde (PFA) was used.
The entire brain with the cervical spinal cord was re-
moved, and superficial, angled rostrocaudal cut was made
on the ventral, left side of the brainstem and spinal cord.
After sectioning this mark allowed us to determine the
orientation and the correct rostrocaudal order of the free-
floating sections.
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After postfixation (4% PFA overnight) and cryoprotec-
tion with 30% sucrose solution (after gradually increased
concentration), cryostat sections of 30 μm thickness
were cut. Thirty serials of sections were collected into 10
wells starting from one millimeter rostrally to the obex.
Every tenth section was used for staining. For the c-Fos
immunohistochemistry free-floating sections were
blocked using 0.3% H2O2 in PBS. After several washes
with PBS containing 1% Triton-X-100 (PBS-T), sections
were incubated with 10% goat serum in PBS-T for an
hour. Incubation with primary antibody for c-Fos (1:
2000, sc-52, Santa Cruz Biotechnology, Dallas, TX, USA)
was performed on a shaker overnight at room
temperature. The reaction was visualized using Vectasta-
tin Elite avidin-biotin kit (PK6101, Vector Laboratories,
Burlingame, CA, USA) with 3,3′-diaminobenzidine
(Sigma-Aldrich, St. Louis, MO, USA) intensified by
nickel-ammonium-sulfate. The specificity of the immune
reaction was tested by omitting the primary antiserum.
The sections were mounted on glass slides and dried
overnight, cleared in xylene, and coverslipped.
Counting of immunopositive cells
An observer blind to the procedures counted the immu-
noreactive cells for c-Fos in laminae I-II of the dorsal
horn using Nikon Optiphot-2 light microscope (Nikon,
Tokyo, Japan) under 10x objective. The cells were also
counted according to the somatotopic representation of
the trigeminal nerve branches (based on Strassman and
Vos, 1993 [13]). The ventral, intermediate, and dorsal
parts of the dorsal horn considered to be equivalent to
the area of the ophthalmic (V/1), maxillary (V/2), and
mandibular (V/3) branch. (Fig. 1b).
Representative photographs were taken by an AxioI-
mager M2 microscope equipped with AxioCam MRc
rev.3 camera (Carl Zeiss, Germany) with a 20x objective.
Statistical analysis
The collected data were analyzed in the 2IS, 2SIF, 4IS,
and 4SIF groups. The effects of treatments on c-Fos cell
numbers in various distances from the obex between the
treated and untreated sides were examined with mixed-
design variance of analysis (MIXED-ANOVA) models
with distance, treatment, and side as repeated measures
(within-subject factor) and group as between-subject fac-
tors. p < 0.05 was considered statistically significant.
Pairwise comparisons were used on estimated marginal
means by taking into account the presence or absence of
interaction; Holm-Sidak method was performed to ad-
just p-values. For the statistical analysis, IBM SPSS 24.0
(IBM Corp, Armonk, NY, USA) was used. For all other
groups, no statistical analysis was used because of the small
sample size and to reduce the number of animals used to aminimum. Graphs were made in GraphPad Prism 8.0.1,
data are showed as mean + SEM on all figures.
Results
Stereotaxic frame
The application of the stereotaxic frame caused bilateral
dense, localized increase in the number of immunoreactive
(IR) cells in the somatotopic area of the maxillary nerve
(maximum cell number (V/2) 24.17 ± 7.96 at obex − 7.5)
(Fig. 2a).
Anesthetic effect (chloral hydrate) and perfusion
The effect of chloral hydrate and the perfusion in the
trigeminal nerve area was negligible (maximum cell
number (V/1) 3.83 ± 1.68 at obex − 0.3, Fig. 2b).
CFA
Dural CFA did not cause noticeable increase in the
number of immunoreactive cells compared to physio-
logical saline neither 2 h nor 4 h after administration.
There was no difference in the number of cells between
the right and left dorsal horns. (Figure not shown.)
However, when the cells were counted based on the
trigeminal somatotopy, substantial increase was found in
the maxillary nerve area (2CFA, 2PHYS), but no differ-
ence was seen between the CFA treated and saline-
treated animals (Fig. 3a, b). A slight increase was ob-
served in the ophthalmic nerve area without any differ-
ence between the two groups. The labeled cell number
was negligible in the mandibular nerve area (Fig. 3a, b).
There was no difference between the 4CFA and
4PHYS groups. The number of c-Fos IR cells was less
after 4 h compared to the 2 h group (Fig. 4.).
Lidocaine
Subcutaneous lidocaine applied on the scalp decreased
the number of c-Fos immunopositive cells compared to
2CFA group, especially in the area of the ophthalmic
branch. Dural application of CFA (Fig. 3c) did not cause
robust changes compared to saline in this case either
(Fig. 3d).
IS
Animals showed significant increase in the number of c-Fos
labeled cells in the spinal trigeminal nucleus caudalis both
2.5 h and 4 h after the dural application of IS (Figs. 5 and 6.).
In the 2.5 h group, these changes were more prominent in
the somatotopic area of the ophthalmic nerve. Two peaks of
activation were found among the rostrocaudal axis. The first
peak is at the level of the obex which follows the activation
pattern of FRE, while the second was at obex (− 2) - (− 6) mm
which in 2IS significantly higher compared to 2SIF. Also, we
found significant difference between the right (ipsilateral)
and left (contralateral) side at the same rostrocaudal levels. A
Fig. 2 Diagrams show the mean number of c-Fos IR neurons in the dorsal horns in NAT a and FRE b groups. Representative photomicrographs
of the dorsal horn from NAT c and FRE groups d. Scale bar: 200 μm. Use of stereotaxic frame caused robust increase of c-Fos positive cells in the
area corresponding to maxillary nerve in NAT group. Number of c-Fos IR cells was minimal in FRE group (maximal cell number 3.83 ± 1.68 in the
ophthalmic nerve area) (mean + SEM)
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the sensory area of the maxillary nerve which is consistent
with the peak found in NAT and is not different among 2IS
and 2SIF. In the mandibular nerve area, the number of la-
beled cells was negligible without any difference between the
groups. The result of the immunohistochemical staining
from the 4SIF and 4IS groups is shown in Fig. 6. The activa-
tion pattern is comparable to the peak seen in 2IS group
after 2.5 h in the V/1 area. The fact that we saw similar acti-
vation pattern in the V/1 area suggests sustained stimulation
of the ophthalmic nerve. The substantial increase in number
of c-Fos IR cells which was seen in the 2SIF and 2IS groups
in V/2 cannot be found in the 4-h survival groups. The num-
ber of c-Fos positive cells in the V/3 area is negligible. After
4 h there was significant difference between 4SIF and 4IS
group which was present both in the dorsal horn and V/1
area (Fig. 6.).Discussion
Fos protein is a widely used marker for locating acti-
vated neuronal populations during nociception [14]. C-
Fos is an immediate-early gene, its transcription starts
within 5 min after the stimulus occurrence [15], and its
expression can be already detected at 30 min [16]. Its
half-life is 2 h, therefore, it is important to plan the ex-
periment and to establish endpoints according to this
time window [17].
Measurement of c-Fos is widely used in headache
models, but it is thought to be unspecific since various
stimuli might change its expression. In the dural inflam-
mation model, used by our group and many others, sur-
gery (anesthesia, stereotaxic frame – V/1, V/2, skin
incision – V/1, etc.) can activate neurons which might
interfere with proper data analysis and could be the pit-
falls of this method (Fig. 1b).
Fig. 3 Diagrams illustrate mean number of c-Fos IR neurons in the dorsal horns 2 h after CFA treatment. The number of the cells is displayed
according to somatotopic representation of V/1, V/2, V/3 in 2CFA a and 2PHYS b groups. Diagrams show the mean number of c-Fos IR cells in
LCFA c and LPHYS d groups. Representative photomicrographs from 2CFA e, 2PHYS f, LCFA g, LPHYS h group showing the right dorsal horns.
Scale bar: 200 μm. Lidocaine decreased the number of c-Fos positive cells compared to 2CFA and 2PHYS group especially in the V/1 area of the
dorsal horns (mean + SEM)
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Fig. 4 Diagrams illustrate the number of c-Fos positive neurons (mean + SEM) 4 h after CFA a or saline b treatment. Representative
photomicrographs of the dorsal horns in 4CFA c, 4PHYS d. Scale bar: 200 μm. Cells were displayed according to somatotopic area of V/1, V/2, V/3
nerve. No difference was seen between 4CFA a and 4PHYS b group
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pattern of the activated cells, we tested the effect of i.p.
anesthetic drug, perfusion, stereotaxic frame, and the
anesthesia of the skin and scalp by lidocaine. The ex-
pression changes were examined in the spinal trigeminal
nucleus caudalis, and the rostrocaudal and somatotopic
distribution was also taken into account to increase
specificity.
It is known for a long time that urethane can cause ac-
tivation in the trigeminal system even without any facial
stimulation. Strassman and Vos found that not just
urethane, but immediate perfusion in pentobarbital
anesthesia causes substantial activation in the caudal
medulla [13]. Based on this study, we decided to exam-
ine the effect of chloral-hydrate anesthesia and perfusion
(FRE group). The number of c-Fos IR cells mildly in-
creased in the V/1 area, but no activation was found in
the area of V/2 and V/3. The rostrocaudal distribution
and the number of c-Fos IR cells were comparable to
the previous findings of Strassman and Vos [13].
A stereotaxic frame is essential in cranial surgeries to
completely stabilize the head and ensure experimental
procedure consistency of each employed animal, but in
our experiment, it caused a robust and highly variable
activation in the area of the maxillary nerve (NAT
group). Animals were held in the frame using three
points; ear bars placed in the ear canals and snout were
fixed by the front incisors. Innervation of the upperfrontal incisors is provided by the maxillary nerve, which
can be responsible for the activation effect seen in the
V/2 area [18]. External ear canal is innervated by auricu-
lotemporal nerve (from V/3), greater and lesser auricular
nerve (from C2, C3 spinal nerves), Arnold’s nerve (from
vagus, glossopharyngeal and facial nerve) [19]. As we did
not witness any increase in the number of activated cells
in the V/3 area, the aforesaid increase in V/2 might be
mainly due to the fixation of the snout. The substantial
activation found in V/1 area is consistent with the
changes seen in FRE group that underwent only
anesthesia and perfusion.
In addition, for a more specific analysis of the effects
of chemical stimulation of the dura, lidocaine was ap-
plied subcutaneously on the scalp (LCFA, LPHYS
groups), before the surgical incision and CFA treatment,
which decreased the number of c-Fos IR cells in the area
of ophthalmic nerve compared to 2CFA and 2PHYS
group. Recent tracing studies suggest that intracranial
and extracranial structures share afferent fibers, which
innervate the dura mater and after penetrating the cal-
varium they supply the periosteum [20, 21]. Surgical in-
cision of the skin can activate these neurons and can
hide the effect of the chemical stimulation of the dura,
thus the use of lidocaine is essential when examining
dural nociception. The distribution of c-Fos in V/2 area
was similar to the NAT group’s activation pattern and
based on the rostrocaudal appearance and variance, we
Fig. 5 Diagrams showing c-Fos immunoreactive cells across different levels of TNC (mean + SEM) in the whole dorsal horn a, c and the V/1 area
b, d 2.5 h after IS a, b, c, d or SIF c, d. Representative photomicrographs showing c-Fos IR cells in the dorsal horns of 2IS e, f, 2SIF groups g, h.
Green highlighting shows the V/1 area in the dorsal horn. Scale bar: 200 μm. We found significant difference between right and left side of the
dorsal horn laminae I-II a, and the ventral part of the dorsal horn b. IS caused significant difference in the number of c-Fos positive cells in the V/
1 area d. Peak at obex follows the activation pattern of FRE, substantial peak at obex (− 6) - (− 8) mm is consistent with the increased number of
cells found in NAT group (*p < 0.05, #p < 0.01, $p < 0.001)
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Fig. 6 Diagrams illustrate number of c-Fos positive cells in 4IS, 4SIF groups a-d. Photomicrographs showing c-Fos expression in the dorsal horns
of 4IS e, f and 4SIF groups g, h. Green highlighting shows the V/1 area in the dorsal horn. Scale bar: 200 μm. IS significantly increases the number
of c-Fos IR neurons both in the whole dorsal horn a and the V/1 area b. IS increased the number of c-Fos positive cells compared to SIF in the
whole dorsal horn c and in the ophthalmic nerve area d (mean + SEM; *p < 0.05, #p < 0.01, $p < 0.001)
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well. These findings might help to identify the effects of
various experimental procedures in the future to make
data analysis easier.
In this study, we applied two different inflammatory
agents on the dura mater, namely CFA and IS. Sub- or
intradermal injection of CFA is commonly used in in-
flammatory and neuropathic pain models: when injected
into hind paw, it caused hyperalgesia and edema with
rapid onset [22]. While the first effects develop in few
hours and peak after 24–72 h, studies also described
long-term complications, such as granulomatous inflam-
mation, skin ulceration, focal necrosis [23]. We chose
2-h and 4-h survival time for CFA groups to avoid
these long-term effects of the treatment. In our experi-
ments, CFA applied over the right hemisphere, with 2-h
survival time, did not cause any difference in the number
of c-Fos positive cells between the right and left dorsal
horns of the spinal trigeminal nucleus. Moreover, no
changes were detected in the number of immunoreactive
cells in the CFA treated and saline group either. When
lidocaine was used to anesthetize the skin (LCFA and
LPHYS groups) before CFA or PHYS treatment, the same
outcome was seen, no difference was found among these
groups. Even with the longer, 4-h survival time, we could
not observe any alterations between the 4CFA and 4PHYS
groups either.
Previous electrophysiological studies showed that
when inflammatory agents are used on the dural surface,
secondary sensitization occurred after the delay of 2–3 h
in the spinal trigeminal nucleus [5, 24]. Adjuvants like
CFA are frequently used for polyclonal antibody produc-
tion in animals; thus, they contain substances which
slow down the breakdown of Mycobacteria, prolonging
its effect [23]. Other studies’ results also support the de-
layed effect of CFA, e.g., its subcutaneous injection can
induce swelling and hyperalgesia with peaks around 24 h
[22]. In a model of parotitis, CFA was injected into the
parotid gland, and increased c-Fos expression was de-
tected in the spinal trigeminal nucleus after 2, 24, 72 h,
which peaked at 72 h [25]. Moreover, it is important to
emphasize that CFA was applied permanently in these
experiments (subcutaneous, intracutaneous application,
or injected into the parotid gland), while we rinsed the
surface of the dura 20 min after application, which might
mitigate its short term effects. The number of studies in-
vestigating dural treatment of CFA is limited; Lukács
et al. applied CFA on the surface of the dura and rinsed
the surface after 20 min, and they described signs of in-
flammation after 4 and 24 h in the trigeminal ganglion;
calcitonin-gene related peptide (CGRP), interleukin-1β
levels were increased compared to saline-treated group
[4]. With longer survival time (seven days), they detected
increased number of c-Fos positive cells in the spinaltrigeminal nucleus [26]. Based on the studies mentioned
above, we can assume that the variances between the site
and the mode of application might induce different ef-
fects (onset and duration), consequently, in different ex-
periments, various neuronal activation and sensitization
patterns were described; the first effects developed over
2, 4 h or more, and in most cases, the peak was between
24 and 72 h. This is consistent with the time course of
delayed-type hypersensitivity reaction, which could be
the main mechanism of action of the CFA application
and can explain the demonstrated variations [27]. In the in-
flammation pain models, the effects of inflammatory medi-
ators are examined in the neurons of the dorsal root
ganglia that are part of the spinothalamic pathway [28], and
information processing might be slightly different in the tri-
geminal system. Hoffman and Matthews found that the
proportion of the sympathetic fibers is higher in spinal
nerves than trigeminal nerves [29]. The function of the
sympathetic nervous system (SNS) in pain processing is not
fully understood: it can play a role in the descending inhib-
ition of pain [30], but on the other hand, studies showed
that catecholamines might be able to sensitize nociceptors
[31]. There is also a link between SNS and immune system;
primary and secondary lymphoid organs receive sympa-
thetic innervation [32], and immune cells express adrener-
gic receptors [33, 34]. In inflammation, immune cells
upregulate alpha-1 receptors which can stimulate release of
proinflammatory cytokines [35, 36]. The higher proportion
of the sympathetic fibers in spinal nerves might be able to
stimulate more immune cells which, probably could initiate
inflammation faster. The main mechanism of action of the
CFA is cell-mediated, this could make it more sensitive to
the variances in the autonomic nervous system compared
to other inflammatory agents [37]. These phenomena might
contribute to our results not showing the activation of the
trigeminal system with shorter survival times.
Edvinsson et al. suggested that sustained trigeminal acti-
vation produced by dural or temporomandibular CFA ad-
ministration could model the transformation from
episodic to chronic migraine [38]. Nociceptor activation
causes release of neuronal mediators like CGRP, which
initiate a local inflammatory response [39] and possibly in-
duce continuous activation and sensitization of the tri-
geminal system [40], creating a self-amplifying process
[41]. This can be paralleled by the effect of repeated mi-
graine attacks, which might generate sustained neurogenic
inflammation or so-called neurogenic neuroinflammation
[38]. As the dural or temporomandibular administration
of CFA can cause prolonged activation of the trigeminal
system with continuous inflammation [4, 42], it might be
able to mimic the chronification process. In our experi-
mental design, it was important to avoid any destruction
or injury on the dura mater; thus, we applied CFA for 20
min and sacrificed the animals after a delay of 2 and 4 h to
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as granulomatous infection and focal necrosis, which
would appear after a longer delay. It is possible that the
time of application or the survival time was too short to
activate the secondary sensory neurons in the spinal tri-
geminal nucleus. As CFA did not cause increase in the
number of c-Fos IR cells in the trigeminal system within this
time frame, its dural application might be more useful in the
investigation of a trigeminal activation with a longer delay.
Sterile inflammation (neurogenic inflammation) can
play a role in the pathomechanism of migraine [43], and
application of IS on the dura mater is widely used to
mimic this process in animals [44, 45]. IS contains in-
flammatory agents; bradykinin, prostaglandin E2, hista-
mine, and serotonin, causing activation of the neurons
directly and indirectly through release of other media-
tors. Activation and sensitization markers can be de-
tected as soon as 20 min after the stimulation in the
first-order neurons, and after 2 h in the second-order
neurons [5, 46]. We examined the number of c-Fos im-
munoreactive cells after dural IS in spinal trigeminal nu-
cleus caudalis. Previous mapping studies helped us to
learn more about the innervation of the dura mater and
the somatotopic representation of the trigeminal nerve
[7, 47]. These studies allowed us to be the first to
present the effect of chemical stimulation in detail.
Compared to SIF, IS caused significant increase in the
number of labeled cells was the most prominent in the
somatotopic area of the ophthalmic nerve, which is re-
sponsible for the somatosensory innervation of the dura
mater [48]. The innervation of the supratentorial dura is
mostly ipsilateral [48], consequently, we found signifi-
cant difference between the right (ipsilateral) and left
(contralateral) caudal spinal trigeminal nucleus. In sev-
eral studies, a catheter was placed into the cisterna
magna or over the parietal hemisphere [49, 50]. If the
mediators are injected to the cisterna magna, side differ-
ences cannot be seen because this area has bilateral in-
nervation and the substance spreads around the cisterna
[51]. The significant difference in the number of c-Fos
IR cells between the IS and SIF groups persists even
after 4 h. From earlier studies, it is known that IS can
cause activation and sensitization of the trigeminal sys-
tem: it has been demonstrated that chemical stimulation
of the dura caused hyperresponsiveness and increased
the receptive field of the TNC neurons [52], and Edel-
mayer et al. presented that dural IS was able to induce
cutaneous allodynia not only in the trigeminal derma-
tome but also in the hind-paws. In their experiments,
withdrawal threshold to von Frey filament stimulation
decreased slowly after dural IS application, reached its
maximum after 3 h, and returned to baseline after 5–6 h
[53]. These findings suggest that the central sensitization
and allodynia is an indirect effect of IS and can explainthe persistent activation found throughout our experi-
mental time points.
Application of IS on the dura mater triggers activation
and sensitization of the trigeminal system, showing sev-
eral similarities with migraine. Allodynia is present in ~
63% of the patients, in the animal model the time course
of the central sensitization is consistent with the cutane-
ous allodynia seen in patients [54, 55]. Many studies dem-
onstrated that IS evoked activation respond to migraine-
specific and non-specific drugs, which supports that the
chemical stimulation model has a place in drug develop-
ment [52, 56]. Though dural application of IS cannot
demonstrate all aspects of the disease, based on these find-
ings it can be a valid animal model of migraine.
Our data support that dural application of IS is a rele-
vant animal model of migraine, however, application of
CFA can be an alternative method if the longer delay of
the latter is taken into account as they recruit leucocytes,
which release inflammatory mediators instead of direct
neuronal activation.
Conclusion
Counting cells according to the somatotopic organization
in the trigeminal system helps the data analysis, chemical
stimulation over the parietal lobe has the most prominent
effect in the ophthalmic nerve area. Based on other’s and
our results, somatotopic representation of the scalp and
the parietal dura mater overlaps; thus, application of lido-
caine is essential to examine the effect of chemical stimu-
lus in a more specific way. In summary, IS applied on the
dura mater can serve as an approach to model acute mi-
graine, while dural application of CFA might be used as a
long-term trigeminal activation model.
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